Reciprocal interaction between monoaminergic systems and the pedunculopontine nucleus: Implication in the mechanism of L-DOPA.

Di Giovanni, Giuseppe; Chagraoui, Abdeslam; Puginier, Emilie; Galati, Salvatore; De Deurwaerdère, Philippe

Di Giovanni, Giuseppe; Chagraoui, Abdeslam; Puginier, Emilie; Galati, Salvatore; De Deurwaerdère, Philippe.

Afiliação

Di Giovanni G; Department of Physiology & Biochemistry, Faculty of Medicine and Surgery, University of Malta, Msida, Malta; Neuroscience Division, School of Biosciences, Cardiff University, Cardiff, UK. Electronic address: giuseppe.digiovanni@um.edu.mt.
Chagraoui A; Normandie Univ, UNIROUEN, INSERM, U1239, CHU Rouen, Neuronal and Neuroendocrine Differentiation and Communication Laboratory, Institute for Research and Innovation in Biomedicine of Normandy (IRIB), Rouen, France; Department of Medical Biochemistry, Rouen University Hospital, Rouen, France.
Puginier E; Normandie Univ, UNIROUEN, INSERM, U1239, CHU Rouen, Neuronal and Neuroendocrine Differentiation and Communication Laboratory, Institute for Research and Innovation in Biomedicine of Normandy (IRIB), Rouen, France; Department of Medical Biochemistry, Rouen University Hospital, Rouen, France.
Galati S; Parkinson and movement Disorders Center Neurocenter of Southern Switzerland, Ospedale Civico di Lugano, Lugano, Switzerland.
De Deurwaerdère P; Centre National de la Recherche Scientifique (Unité Mixte de Recherche 5287), 146 rue Léo Saignat, B.P.281, F-33000 Bordeaux Cedex, France. Electronic address: philippe.de-deurwaerdere@u-bordeaux.fr.

Neurobiol Dis ; 128: 9-18, 2019 08.

Article em En | MEDLINE | ID: mdl-30149181

Assuntos

Neurônios Adrenérgicos/fisiologia; Antiparkinsonianos/uso terapêutico; Neurônios Dopaminérgicos/fisiologia; Levodopa/uso terapêutico; Doença de Parkinson/tratamento farmacológico; Núcleo Tegmental Pedunculopontino/metabolismo; Neurônios Serotoninérgicos/fisiologia; Animais; Antiparkinsonianos/farmacologia; Humanos; Levodopa/farmacologia; Doença de Parkinson/metabolismo; Núcleo Tegmental Pedunculopontino/efeitos dos fármacos

Palavras-chave

Behavior; Dopamine; Gait; L-DOPA; Mesencephalic locomotor region (MLR); Noradrenaline; Parkinson's disease; Serotonin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Levodopa / Núcleo Tegmental Pedunculopontino / Neurônios Dopaminérgicos / Neurônios Adrenérgicos / Neurônios Serotoninérgicos / Antiparkinsonianos Limite: Animals / Humans Idioma: En Revista: Neurobiol Dis Assunto da revista: NEUROLOGIA Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google